The short version Semaglutide is a once-a-week injection that quiets appetite by copying a hormone your gut already makes. In the major studies, people lost about 15% of their body weight over roughly a year, but it's a prescription medicine that works alongside eating changes and movement, not instead of them.

You've seen the headlines and probably know someone who's tried it. Here's what's actually going on underneath the hype, without the marketing spin.

Where it came from

Semaglutide started life as a diabetes medicine. Doctors noticed people taking it were also losing weight, and in June 2021 the FDA approved a higher-dose version (sold as Wegovy®) specifically for weight management. In March 2024, it picked up another approval: in adults with obesity, it can also lower the risk of serious heart problems like heart attack and stroke, the first weight medicine to be cleared for that.

How it works, in plain English

After you eat, your gut releases a hormone called GLP-1 that tells your brain you're satisfied and slows down how fast your stomach empties. Semaglutide imitates that hormone. The result: you feel full sooner and stay full longer, so eating less doesn't take constant willpower. It's not a stimulant and it's not "speeding you up", it's turning down hunger.

What the studies actually showed

The approval came from a big research program called STEP. In the first major trial, published in the New England Journal of Medicine in 2021, adults taking weekly semaglutide lost about 15% of their body weight on average over 68 weeks, far more than the placebo group. A 2024 analysis found roughly 68% of people lost at least 5% of their weight and 44% lost at least 10%. And when researchers followed people out to two years, the weight loss held steady.

Who it's meant for

The FDA approval is specific about who qualifies:

If your BMI is...You may qualify when...
30 or higherOn its own (obesity)
27 to 29.9Plus a related condition, high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea

In every case it's meant to go together with a reduced-calorie way of eating and more physical activity, the medicine makes those changes easier to stick to, not unnecessary.

Side effects to expect

The most common complaints are stomach-related: nausea, diarrhea, constipation, and headaches. For most people these are strongest early on and settle as the body adjusts, which is why doses are increased slowly. Because it's a prescription medicine, a physician needs to review your health history and other medications before you start.

A quick note: This is general information, not medical advice. Whether semaglutide is a fit depends on your individual health, that's a conversation to have with a physician who can look at the full picture.

Where this comes from

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM, 2021. nejm.org
  2. U.S. FDA, Wegovy heart-risk approval, March 2024. fda.gov
  3. Ghusn W, et al. Semaglutide for overweight and obesity: a review. NIH PMC
← Back to The Blog